My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 522

    1.

    Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.

    Pillunat LE, Larsson LI; European and Canadian Latanoprost Study Group.

    Br J Ophthalmol. 2003 Dec;87(12):1492-6.PMID: 14660460 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.

    DuBiner HB, Mroz M, Shapiro AM, Dirks MS; Brimonidine vs. Latanoprost Study Group.

    Clin Ther. 2001 Dec;23(12):1969-83.PMID: 11813932 [PubMed - indexed for MEDLINE]Related articles

    3.

    Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.

    Simmons ST, Samuelson TW.

    Clin Ther. 2000 Apr;22(4):388-99.PMID: 10823361 [PubMed - indexed for MEDLINE]Related articles

    4.

    Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.

    Simmons ST, Earl ML; Alphagan/Xalatan Study Group.

    Ophthalmology. 2002 Feb;109(2):307-14; discussion 314-5.PMID: 11825814 [PubMed - indexed for MEDLINE]Related articles

    5.

    Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.

    García Sanchez J.

    Eur J Ophthalmol. 2000 Jul-Sep;10(3):198-204.PMID: 11071026 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America.

    Susanna R Jr, Sheu WP; Latin American Glaucoma Society.

    Clin Ther. 2004 May;26(5):755-68.PMID: 15220019 [PubMed - indexed for MEDLINE]Related articles

    7.

    Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.

    Petounis A, Mylopoulos N, Kandarakis A, Andreanos D, Dimitrakoulias N.

    J Glaucoma. 2001 Aug;10(4):316-24.PMID: 11558817 [PubMed - indexed for MEDLINE]Related articles

    8.

    Comparison of the intraocular pressure lowering effect of latanoprost and carteolol-pilocarpine combination in newly diagnosed glaucoma.

    Ozdemir M, Ozdemir G.

    Jpn J Ophthalmol. 2003 Jan-Feb;47(1):72-6.PMID: 12586182 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure.

    Dubiner HB, Sircy MD, Landry T, Bergamini MV, Silver LH, Darell Turner F, Robertson S, Andrew RM, Weiner A, Przydryga J.

    Clin Ther. 2004 Jan;26(1):84-91.PMID: 14996520 [PubMed - indexed for MEDLINE]Related articles

    10.

    Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States.

    Camras CB, Sheu WP; United States Latanoprost-Brimonidine Study Group.

    J Glaucoma. 2005 Apr;14(2):161-7.PMID: 15741820 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intraocular pressure-lowering effects of latanoprost and brimonidine therapy in patients with open-angle glaucoma or ocular hypertension: a randomized observer-masked multicenter study.

    Kampik A, Arias-Puente A, O'Brart DP, Vuori ML; European Latanoprost Study Group.

    J Glaucoma. 2002 Apr;11(2):90-6.PMID: 11912355 [PubMed - indexed for MEDLINE]Related articles

    12.

    A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.

    Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.

    Clin Ther. 2006 Mar;28(3):332-9.PMID: 16750448 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.

    Bucci MG.

    J Glaucoma. 1999 Feb;8(1):24-30.PMID: 10084271 [PubMed - indexed for MEDLINE]Related articles

    14.

    Latanoprost : an update of its use in glaucoma and ocular hypertension.

    Perry CM, McGavin JK, Culy CR, Ibbotson T.

    Drugs Aging. 2003;20(8):597-630. Review.PMID: 12795627 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.

    Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.

    Ann Pharmacother. 2008 Apr;42(4):498-504. Epub 2008 Mar 25.PMID: 18364402 [PubMed - indexed for MEDLINE]Related articles

    16.

    A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension.

    Diestelhorst M, Larsson LI; European Latanoprost Fixed Combination Study Group.

    Br J Ophthalmol. 2004 Feb;88(2):199-203.PMID: 14736774 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

    Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group.

    Am J Ophthalmol. 2003 Jan;135(1):55-63.PMID: 12504698 [PubMed - indexed for MEDLINE]Related articles

    18.

    A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.

    Maul E, Carrasco FG, Costa VP, Casiraghi JF, Vargas E, Sarmina JS, Mayol R.

    Clin Ther. 2007 Sep;29(9):1915-23.PMID: 18035191 [PubMed - indexed for MEDLINE]Related articles

    19.

    The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.

    Diestelhorst M.

    Graefes Arch Clin Exp Ophthalmol. 2000 May;238(5):433-9.PMID: 10901475 [PubMed - indexed for MEDLINE]Related articles

    20.

    Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

    Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group.

    Am J Ophthalmol. 2001 Oct;132(4):472-84.PMID: 11589866 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity